Skip to main content
Parsaclisib a promising treatment option in BTKi-naive relapsed or refractory MCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Parsaclisib a promising treatment option in BTKi-naive relapsed or refractory MCL
User login
Username
Password
Reset your password
Concept
Lead
score
Mantle Cell Lymphoma
1
1
Refractory
0
0.89
Lymphoma
0
0.3
Tyrosine Kinase Inhibitor
0
1
Tyrosine Kinase
0
0.15
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.76
Edit Tags